Cognito is developing disease-modifying treatments to revive the health and well-being of patients living with Alzheimer’s.
Location: United States
Total raised: $105M
Investors 1
| Date | Name | Website |
| - | FoundersX ... | foundersx.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.03.2026 | Series C | $105M | - |
Mentions in press and media 18
| Date | Title | Description |
| 09.03.2026 | Cognito Therapeutics Nets $105 Million Series C | CAMBRIDGE, MA, Cognito Therapeutics, a late clinical-stage neurotechnology company, announced the final close of its oversubscribed $105 million Series C funding. >> Click here for more funding data on Cognito Therapeutics >> T... |
| 05.03.2026 | Cognito Therapeutics Raises $105M in Series C Funding | Cognito Therapeutics, a Cambridge, MA-based clinical-stage neurotechnology company, raised $105M in Series C funding. The round was led by Morningside Ventures, IAG Capital Partners and Starbloom Capital, with participation from new investo... |
| 13.03.2025 | Neuromod's €10M Financing: A New Dawn for Tinnitus Treatment | In the world of medical technology, innovation is the lifeblood. Neuromod Devices Ltd., a Dublin-based company, has just injected a fresh dose of vitality into the tinnitus treatment landscape. With a recent €10 million ($10.9 million) equi... |
| 12.03.2025 | Irish company Neuromod scores $10.9M for tinnitus medical device | Photo: martin-dm/Getty Images Neuromod, a medical device company out of Dublin focused on treating tinnitus, secured €10 million ($10.9 million) in equity financing, expanding its Series B raise. The raise builds on the company's €10.5 mill... |
| 12.03.2024 | MIT Introduces Noninvasive Treatment for 'Chemo Brain' That Involves Lights and Sounds | Jace Dela Cruz, Tech Times 12 March 2024, 09:03 am The Massachusetts Institute of Technology (MIT) has introduced a potential noninvasive treatment to address the cognitive impairments associated with chemotherapy, known as "chemo brai... |
| 29.01.2024 | Cognito Therapeutics raises $35M Series B extension | The company raised a $73 million round in March of 2023 Alzheimer’s disease affects nearly 6 million Americans. It's the sixth leading cause of death among all adults and the fifth leading cause for those aged 65 or older, and the problem i... |
| 11.10.2023 | MDisrupt raises $3M seed to bring medical expertise to healthtech innovators | It's the people, platform, and data that make a successful product These days, you don’t have to have a medical degree to develop innovative health technology. But you still need lots of in-depth medical intelligence. Well, for that, you ca... |
| 17.08.2023 | The 30 young leaders who are forging a new future for the healthcare industry in 2023 | Your browser does not support the video element. This story is available exclusively to Insider subscribers. Become an Insider and start reading now. A new generation of leaders is transforming the healthcare industry. They're developing ne... |
| 24.03.2023 | StartUPDATES: New Developments from Healthcare Startups | A new medical device has been developed that promises to revolutionize the way peritoneoscopy is performed. OUI Medical has completed a cadaver study using its peritoneoscope, a portable handheld scope with an integrated camera, screen, pro... |
| 23.03.2023 | Cognito Therapeutics raises $73M to advance study on Alzheimer's patients | The company's wearable uses light and sound to restore electrical activity in the brain Alzheimer’s affects more than 6 million Americans, most of them over the age of 65, and is the seventh leading cause of death in the U.S. making it one ... |
Show more